We found that the level of transgelin-2 was significantly higher in KRAS G12 mutant pancreatic cancer cell lines than in wild-type or other types of KRAS (G13D, Q61R, I171M, A146T, etc.)(Fig. 1d). This evidence concerns the gene TAGLN2 and familial pancreatic carcinoma.